Home

Ocugen stock news today

Ocugen, Inc. (OCGN) Stock Price, News, Quote & History ..

PR Newswire · 06/18 17:03. Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) MALVERN, Pa., June 18, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save. MALVERN, Pa., June 16, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it is set to join the. Additional Formats OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today Better-than-expected trials should boost OCGN's efforts to bring the Covid-19 vaccine to the U.S Inside the Covid-19 vaccine deal that boosted Ocugen's stock price by 800%. January 7, 2021 Philadelphia Business Journal. While Ocugen has focused on developing gene therapy treatments for retinal diseases since its inception in 2013, the Malvern biopharmaceutical company expanded into a new arena two weeks ago Find real-time OCGN - Ocugen Inc stock quotes, company profile, news and forecasts from CNN Business

Ocugen's stock fell sharply last week, following the news that it would no longer pursue an EUA. Although its stock rebounded slightly today, investors are understandably concerned that any. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ocugen was a penny stock is up 180% for the year. But all good things must come to an end. And its time to let go of OCGN stock. The post Ocugen Has Had a Good Run, but the Math Says Its Over appeared first on InvestorPlace

OCGN News Today (Ocugen) MarketBea

InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Today, speculative growth plays are once again in focus for investors. Indeed, biopharma stocks such as Ocugen (NASDAQ: OCGN) have. Ocugen Inc () Stock Market info Recommendations: Buy or sell Ocugen stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Ocugen share forecasts, stock quote and buy / sell signals below.According to present data Ocugen's OCGN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists) Shares of Ocugen ( NASDAQ:OCGN) dropped more than 3% on Friday. The stock opened at $7.46, but by 2:30 p.m., it was down to $7.25. Ocugen's stock is still up more than 295% for the year. IMAGE. Indeed, biopharma stocks such as Ocugen (NASDAQ:OCGN) have taken off today on this surge in positive retail investor sentiment. Currently, OCGN stock is up more than 18% at the time of writing on. Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's shares had closed nearly 2% lower at $8.46 in the.

Ocugen has swung to new highs and lows this year on news around its partnership for Covaxin. Today's announcement could stoke further progress speculation.More From InvestorPlace Stock Prodigy Who. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Ocugen (NASDAQ: OCGN) is not having the best of mornings.The company, once seen as a serious underdog in the Covid-19 vaccine race. $OCGN BREAKOUT? OCUGEN BIG NEWS! IS THIS A $10 STOCK? Subscribe For Daily Videos: https://bit.ly/2JFrpbv️ Join Discord community: https://discord.gg/Jq6s.. A high-level overview of Ocugen, Inc. (OCGN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools

By Jul. 7, OCGN stock was down to $7.16 — a pretty good discount and an opportunity to grab some shares at a reasonably favorable price point. Today, it still trades at that $7 level. A Critical. Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved eye diseases. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug - one to many and our novel biologic product candidate. In the context of predicting Ocugen's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ocugen's historical news coverage. Ocugen's after-hype downside and upside margins for the prediction period are 0.37 and 17.58, respectively. We have considered. Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's shares had closed nearly 2% lower at $8.46 in the regular session, the day prior. Ocugen is the top-trending stock on Stocktwits at press time and also seeing.. Ocugen Inc OCGN shares gained 13.71% to $8.71 Thursday after the company announced it's on track to submit its Emergency Use Authorization application to the FDA for its COVID-19 vaccine candidate.

News Ocugen Inc.OCGN. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from. Get Ocugen Inc (OCGN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today Ocugen's Indian vaccine development partner reported better-than-expected results from its local Covid-19 vaccine trials. OCGN stock has been on a roller-coaster ride on every Covaxin rumor and news item View today's stock price, news and analysis for Ocugen Inc. (OCGN). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more

OCGN Stock Price Ocugen Inc

  1. Get the latest news and real-time alerts from Ocugen, Inc. (OCGN) stock at Seeking Alpha
  2. ds investors of the upco
  3. View live Ocugen, Inc chart to track its stock's price action. Find market predictions, OCGN financials and market news
  4. Today we talk about the Ocugen stock news and future share price prediction, because the Ocugen (OCGN) share price has had some serious spikes, but not every..
  5. The Ocugen Inc stock price fell by -3.07% on the last day (Friday, 9th Jul 2021) from $7.50 to $7.27.During the day the stock fluctuated 4.79% from a day low at $7.13 to a day high of $7.47.The price has fallen in 6 of the last 10 days and is down by -11.02% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock
  6. g out (getting discovered) this weekend I think we have some really nice shorts to squeeze hard co

OCGN Ocugen — Stock Price and Discussion Stocktwit

  1. OCGN stock quote, chart and news. Get Ocugen, Inc.'s stock price today
  2. Ocugen stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ocugen daily returns and investor perception about the current pice of Ocugen Inc as well as its diversification or hedging effects on your existing portfolios
  3. With a casino-like mentality in the stock market today, this makes Ocugen an obvious favorite for specific risk-seeking investors. That being said, more conservative investors might decide to.
  4. Ocugen Inc. (OCGN) stock has rocketed from penny stock status in recent months as the company, a biopharmaceutical firm developing gene therapies for eye diseases, has turned its attention to developing a Covid-19 vaccine.. The share price climbed from a low of just $0.17 in mid-2020 to start 2021 at $3.07 per share. The stock rocketed to $15.81 per share on February 8, and has been trading.
  5. Ocugen will issue a pre-market earnings announcement the same day. Investors are invited to participate on the call using the following details:. Ocugen Inc. stock has also gained 14.72% of its value over the past 7 days. However, OCGN stock has inclined by 3305.57% in the 3 months of the year
  6. ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors With Losses In Excess Of $100K To Secure Counsel Before Important Deadline- OCGN. By PR Newswire. Jun 18, 2021 8:03 PM EDT.

OCGN Stock Forecast, Price & News (Ocugen) MarketBea

  1. Ocugen (OCGN) to File Coronavirus Vaccine BLA in US, Stock Tanks. by Zacks Equity Research Published on June 11,2021. Ocugen (OCGN) to submit a BLA for its COVID-19 vaccine candidate, Covaxin, in.
  2. What occurred Shares of Ocugen (NASDAQ:OCGN) rose on Tuesday after the biotechnology firm struck a take care of Jubilant HollisterStier to Why Ocugen Stock Rallied Today | 198 Financial News Wednesday, July 7, 202
  3. OCGN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 17, 2021 in the Class Action Filed on Behalf of Ocugen, Inc. Limited Shareholders Newsfile Corp - Fri Jul 2, 9:49AM CDT. CMTX - Fri Jul 2, 9:49AM CDT. New York, New York-- (Newsfile Corp. - July 2, 2021) - The Klein Law Firm announces that a class action complaint has.
  4. View Ocugen, Inc. OCGN investment & stock information. Get the latest Ocugen, Inc. OCGN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more

OCGN news, real time OCGN stock news, Ocugen Inc news

Get the latest Ocugen Inc (OCGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions Ocugen shares shot 16% higher premarket. On Friday, trading of the biopharmaceutical company was briefly halted amid high volatility after it announced a direct offering of its common stock Ocugen Inc. (NASDAQ:OCGN) went down by -7.40% from its latest closing price compared to the recent 1-year high of $18.77. The company's stock price has collected -20.07% of loss in the last five trading sessions. Press Release reported on 03/18/21 that Thinking about buying stock in Lordstown Mot Today, speculative growth plays are once again in focus for investors. Indeed, biopharma stocks such as Ocugen (NASDAQ:OCGN) have taken off today on this surge in positive retail investor sentiment.Currently, OCGN stock is up more than 18% at the time of writing on today's price action Shares of Ocugen, Inc. (OCGN) stock were down in the per market trading session today after recording the gain of 6.69% with an $11.96 per share price. OCGN stock price went down by 3.60% to drop at $11.53 a share at the time of this writing

Press Releases Ocugen, Inc

Keep In Touch. © 2021 Ocugen, Inc. All Rights Reserved Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19 Investorplace.com - OCGN Stock : The Big Covaxin News That Has Ocugen Rallying Today. News. Close. Vote. Posted by. Moderator. 5 minutes ago. Investorplace.com - OCGN Stock : The Big Covaxin News That Has Ocugen Rallying Today Ocugen, Inc. (NASDAQ:OCGN)'s Major holders. If we look at who the major shareholders are, we find that insiders hold 2.49% of Ocugen, Inc. shares while 12.62% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 12.94% Below are the latest news stories about Ocugen Inc that investors may wish to consider to help them evaluate OCGN as an investment opportunity. The Outlook for Ocugen Stock Has Deteriorated Further Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for.

OCGN Stock: The Big Covaxin News That Has Ocugen Rallying

  1. Ocugen Inc. (NASDAQ:OCGN) went up by 5.94% from its latest closing price compared to the recent 1-year high of $18.77. The company's stock price has collected 31.57% of gains in the last five trading sessions. Press Release reported on 04/30/21 that Thinking about buying stock in Farmmi, Microvis
  2. For the readers interested in the stock health of Ocugen Inc. (OCGN). It is currently valued at $8.66. When the transactions were called off in the previous session, Stock hit the highs of $9.28, after setting-off with the price of $9.04. Company's stock value dipped to $8.66 during the trading o
  3. OCGN Stock: Ocugen Flies on COVID-19 News. March 3, 2021 by Joshua Rodriguez. Ocugen Inc (NASDAQ: OCGN) is up big in the market this morning, and for good reason. The company released interim.
  4. Latest Share Price and Events. Stable Share Price: OCGN is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 23% a week. Volatility Over Time: OCGN's weekly volatility has decreased from 57% to 23% over the past year, but is still higher than 75% of US stocks

Ocugen's stock fell sharply last week, following the news that it would no longer pursue an EUA. Although its stock rebounded slightly today, investors are understandably concerned that any profits the biotech could potentially earn from Covaxin are now likely delayed until 2022 and perhaps even later The company hasn't issued any news today. Nonetheless, there's a good reason for the run. Here's what's going on with OCGN stock: While Ocugen stock does come with risk, they all do. Ocugen Inc. Announces $100 Million Registered Direct Offering of Common Stock Priced at a Premium to Market GlobeNewswire Inc. - 4/23/2021 3:00:00 PM Ocugen shares surge for second day in a row on vaccine data; close up 43% today Seeking Alpha - 4/22/2021 4:33:26 P

News & Events Ocugen, Inc

  1. Ocugen Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule. September 08, 2020 16:25 ET | Source: Ocugen. Ocugen. Malvern, Pennsylvania, UNITED STATES. MALVERN, Pa., Sept.
  2. Latest OCUGEN (OCGN) stock news, Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events
  3. This news has caused our stock price to fall $ 2.62 Close per share or at 28% $ 6.69 Per share June 10, 2021, Which hurt investors. The complaint alleges that throughout the class, the defendant not only made materially false and / or misleading statements, but also did not disclose materially unfavorable facts about the company's business.

Ocugen reported a $0.04 net loss per share for the three months ended March 31, 2021 compared to a $0.07 net loss per share for the three months ended March 31, 2020. Conference Call and Webcast Details. Ocugen has scheduled a conference call and webcast for 8:30 a.m. eastern time today to discuss the financial results and recent business. Ocugen Inc (Ocugen Inc ()) has gained Monday morning, with the stock gaining 76.19% in pre-market trading to 9.25.OCGN's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market Ocugen's speculative appeal is noteworthy. Therefore, it's understandable that speculators might want to take a chance with this stock. Should the FDA approve COVAXIN, investors can expect to see a near-term surge. With a casino-like mentality in the stock market today, this makes Ocugen an obvious favorite for specific risk-seeking investors

OCGN - Ocugen Inc Stock quote - CNNMoney

The average Ocugen stock price prediction forecasts a potential downside of N/A from the current OCGN share price of $7.27. What is OCGN's Earnings Per Share (EPS) forecast for 2021-2023? (NASDAQ: OCGN) Ocugen's current Earnings Per Share (EPS) is -$0.28. On average, analysts forecast that OCGN's EPS will be $-0.18 for 2021, with the lowest EPS. On this news, Ocugen's stock price fell $2.62 per share, or 28.14%, to close at $6.69 per share on June 10, 2021. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation

Ocugen Inc. (NASDAQ:OCGN) price is hovering lower on Tuesday, June 22, dropping -4.59% below its previous close. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. A look at today's price movement shows that the recent level at last check reads $7.4 The stock price of Ocugen Inc (NASDAQ: OCGN) is trading at over 150% as of 11:26 AM ET today. This is why it happened. The stock price of Ocugen Inc (NASDAQ: OCGN) — a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19 — is trading at over 150% as of 11:26 AM ET today OCGN stock news. Ocugen announced that it completed its public stock offering and raised an impressive $23 million in new capital that will be used by the company to fund its partnership with.

Ocugen stock has a median target price of $1, which is a premium of 24 percent over its closing prices on Dec. 22. Analysts might take a new look at the stock after the deal with Bharat Biotech. Eye-Drug Firm Ocugen Triples After Direct Offering. In a direct offering, eye-drug developer Ocugen sold 3 million shares at $7.65, 46% above Friday's close. The stock leaped on Monday. Ocugen. You can buy and sell Ocugen, Inc (OCGN) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details Stock analysis for Ocugen Inc (OCGN:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile

4 days OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today InvestorPlace . InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ocugen's Indian vaccine development partner reported better-than-expected results from its local Covid-19 vaccine trials With Ocugen stock trading at $7.29 per share, the total value of Ocugen stock (market capitalization) is $1.45B. Ocugen stock was originally listed at a price of $704.99 in Dec 3, 2014. If you had invested in Ocugen stock at $704.99, your return over the last 6 years would have been -98.97%, for an annualized return of -53.32% View detailed financial information, real-time news, videos, quotes and analysis on Ocugen Inc (NASDAQ:OCGN). Explore commentary on Ocugen Inc and hear what the experts at TheStreet are saying.

ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors With Losses Over $500K to Secure Counsel Before Important August 17 Deadline in Securities Class Action - OCG Ocugen is the latest penny stock to win the favor of retail investors looking for the next big thing. OCGN is moving down some 9% on Tuesday, shrugging off the FDA news. Update: Tuesday's trading. Ocugen, Inc.(NASDAQ:OCGN): Although shares of Ocugen (OCGN) have rallied over the past month in response to the company's announcement of plans to co-develop a COVID-19 vaccine candidate with India's Bharat Biotech, the vaccine's commercialization prospects look bleak. In addition to that, given the stock's high valuation even though the company has no revenue-generating products in.

Why Ocugen Stock Rallied Today The Motley Foo

To say that Ocugen stock has been hot this year would be one of the biggest understatements of the decade. Ocugen Inc. (NASDAQ: OCGN) has seen its stock price gain 592% so far this year and almost. Shares of Ocugen, Inc. (OCGN) stock were popping high today on May 7, 2021, ahead of today's earnings report.OCGN stock price saw a surge of 7.83% to reach $10.33 a share at the time of this writing. OCGN stock was down for the past three days and dropped 12.19% at the previous closing

Latest News Ocugen Inc Stock ( OCGN

Jubilant HollisterStier to manufacture COVAXIN™ in the US. MALVERN, Pa., June 15, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it has. Ocugen, Inc., a biopharmaceutical company, and Hyderabad-based Bharat Biotech have announced an agreement to co-develop, supply and commercialise the latter's Covaxin, an advanced stage whole. Ocugen Reports $100 Million Direct Share Offering at Market Premium from Institutional Investors. Join our investor club Mobile App Services for public companies News The stock traded today. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Ocugen has swung to new highs and lows this year on news around its partnership for Covaxin. Today's announcement could stoke further progress speculation. The post OCGN Stock: The Big FDA News Lifting Ocugen Shares Today appeared first on InvestorPlace. More From InvestorPlac

Ocugen's stock was trading approximately 19% higher to $11.44 on Monday at the time of publication. The stock has a 52-week high of $18.77 and a 52-week low of $0.17. Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements Historical daily price data is available for up to two years prior to today's date. For more data, Barchart Premier members can download more historical data (going back to Jan. 1, 1980) and can download Intraday, Daily, Weekly, Monthly or Quarterly data on the Historical Download tab.Additional underlying chart data and study values can be downloaded using the Interactive Charts The stock price of Ocugen Inc (NASDAQ: OCGN) increased by 10.72% today as it went from a previous close of $9.18 to $10.17. Investors appear to be responding to a few catalysts. Investors are responding to Ocugen being in continued discussions with the U.S. Food and Drug Administration (FDA) over the development of COVAXIN Malvern-based Ocugen saw its stock nearly triple last week after the company signed a letter of intent with Bharat Biotech to co-develop the India-based company's COVID-19 vaccine candidate for the U.S. market, writes John George for the Philadelphia Business Journal. After the announcement on Tuesday, Ocugen's stock soared by 92 percent and continued its climb to close up 178 percent at. In depth view into OCGN (Ocugen) stock including the latest price, news, dividend history, earnings information and financials

OCGN stock: The Big COVAXIN News Boosting Ocugen Today

Drug developer Ocugen Inc said on Tuesday it had partnered with Bharat Biotech to co-develop the India-based company's COVID-19 vaccine candidate for the U.S. market Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene. The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued. 263.2% Why Ocugen Stock Is Moving Today. Ocugen Inc (NASDAQ: OCGN) shares gained 13.71% to $8.71 Thursday after the company announced it's on track to submit its Emergency Use Authorization

Malvern-Based Ocugen’s Stock Nearly Triples After Inking

High volatility in Ocugen Inc stock price on Tuesday which ended trading at $6.26 StockInvest.us - 6/15/2021 8:08:41 PM Hot Stocks: Bitcoin stocks still in focus, DKNG falling on research call, more drug development news Seeking Alpha - 6/15/2021 9:11:00 A News for Ocugen Inc. Tuesday, June 15, 2021. 08:42 AM ET. Ocugen's stock is up 14% after announcing manufacturing partner for experimental COVID-19 shot MarketWatch. Monday, May 03, 2021. 10:52 AM ET. Ocugen's stock is up after sharing preprint about COVID-19 vaccine effectiveness against lesser known Brazilian variant MarketWatch. Tuesday. In addition, this page includes various stock data for Ocugen, such as the latest Ocugen stock price history, total returns, stock price today in addition to fundamental data such as earnings and dividends as well as valuation measures such as dividend yield and PE ratio. Get the free 2021 Dogs of the Dow Checklist

The Biotech “Millionaire Maker” Stock To Avoid Right NowOcgn Stock Price Today : Ocgn Stock Why Vaccine PlayWhy Ocugen Stock Is Tanking Today | The Motley FoolOcgn Stock Offering : Saudi stock offering creates world'sWhy Ocugen Stock Skyrocketed TodayOcugen Inc (OCGN) is down 6

MALVERN, Pa., and HYDERABAD, India, July 02, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that its co-development partner, Bharat Biotech. What's Happening With Ocugen Inc Stock Today? Ocugen Inc (OCGN) stock is higher by 20.62% while the S&P 500 has fallen -0.16% as of 2:29 PM on Friday, Feb 26. OCGN is higher by $1.65 from the previous closing price of $8.00 on volume of 51,067,022 shares. Over the past year the S&P 500 is higher by 28.35% while OCGN is higher by 2253.66% Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on. Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it has selected Jubilant HollisterStier of Spokane, Washington as its manufacturing partner for COVAXIN™ to prepare for potential commercial manufacturing of.